Yun Nadezhda E, Peng Bi-Hung, Bertke Andrea S, Borisevich Viktoriya, Smith Jennifer K, Smith Jeanon N, Poussard Allison L, Salazar Milagros, Judy Barbara M, Zacks Michele A, Estes D Mark, Paessler Slobodan
Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555-0609, United States.
Vaccine. 2009 Jun 19;27(30):4064-73. doi: 10.1016/j.vaccine.2009.04.015. Epub 2009 May 3.
Studying the mechanisms of host survival resulting from viral encephalitis is critical to the development of vaccines. Here we have shown in several independent studies that high dose treatment with neutralizing antibody prior to intranasal infection with Venezuelan equine encephalitis virus had an antiviral effect in the visceral organs and prolonged survival time of infected mice, even in the absence of alphabeta T cells. Nevertheless, antibody treatment did not prevent the development of lethal encephalitis. On the contrary, the adoptive transfer of primed CD4(+) T cells was necessary to prevent lethal encephalitis in mice lacking alphabeta T cell receptor.
研究病毒性脑炎导致宿主存活的机制对于疫苗开发至关重要。在几项独立研究中,我们发现,在用委内瑞拉马脑炎病毒经鼻感染之前,用中和抗体进行高剂量治疗对内脏器官具有抗病毒作用,并延长了感染小鼠的存活时间,即便在缺乏αβT细胞的情况下亦是如此。然而,抗体治疗并不能预防致死性脑炎的发生。相反,对于缺乏αβT细胞受体的小鼠,过继转移经致敏的CD4(+) T细胞对于预防致死性脑炎是必要的。